Share

Vir Biotechnology CEO George Scangos at annual J.P. Morgan Healthcare Conference

Vir Biotechnology CEO George Scangos speaks with CNBC from the 38th Annual J.P. Morgan Healthcare Conference.
05:58
Tue, Jan 14 20202:40 PM EST